Abstract: Fifteen pyrrole alkaloids were isolated from the Red Sea marine sponge Stylissa carteri and investigated for their biological activities. Four of them were dibrominated [(+) dibromophakelline, Z-3-bromohymenialdisine, (±) ageliferin and 3,4-dibromo-1H-pyrrole-2-carbamide], nine compounds were monobrominated [(−) clathramide C, agelongine, (+) manzacidin A, (−) 3-bromomanzacidin D, Z-spongiacidin D, Z-hymenialdisine, 2-debromostevensine, 2-bromoaldisine and 4-bromo-1H-pyrrole-2-carbamide)] and finally, two compounds were non-brominated derivatives viz., E-debromohymenialdisine and aldisine. The structure elucidations of isolated compounds were based on 1D & 2D NMR spectroscopic and MS studies, as well as by comparison with literature. In-vitro, Z-spongiacidin D exhibited a moderate activity on (ARK5, CDK2-CycA, CDK4/CycD1, VEGF-R2, SAK and PDGFR-beta) protein kinases. Moreover, Z-3-bromohymenialdisine showed nearly similar pattern. Furthermore, Z-hymenialdisine displayed a moderate effect on (ARK5 & VEGF-R2) and (−) clathramide C showed a moderate activity on AURORA-A protein kinases. While, agelongine, (+) manzacidin A, E-debromohymenialdisine and 3,4-dibromo-1H-pyrrole-2-carbamide demonstrated only marginal inhibitory activities. The cytotoxicity study was evaluated in two different cell lines. The most effective secondary metabolites were (+) dibromophakelline and Z-3-bromohymenialdisine on L5178Y. Finally, Z-hymenialdisine, Z-3-bromohymenialdisine and (±) ageliferin exhibited the highest cytotoxic activity on HCT116. No report about inhibition of AURORA-A and B by hymenialdisine/hymenialdisine analogs existed and no reported toxicity of ageliferin existed in literature.
Introduction
Marine sponges (Phylum: Porifera) have attracted substantial research interest because of their ecological importance and their production of a wide range of bioactive compounds for pharmacological use [1, 2] . The Red Sea is a unique and largely unexplored marine ecosystem, where its sponges have been studied during the past two decades for their natural products and bioactive constituents, as well as for their ecological importance [3] .
A review demonstrated that pyrrole alkaloids showed promising biological activities, as hymenialdisine, first isolated in 1980 from the marine sponges of the genera Hymeniacidon, Acanthella, Axinella and Pseudaxinyssa [4] .
Hymenialdisine and dibromocantharelline are marine sponge alkaloids with unique biological activity. They are well-known protein kinase inhibitors; namely, hymenialdisine potently inhibited glycogen synthase kinase 3β, cyclin-dependent kinase 2 and cyclin-dependent kinase 5, while dibromocantharelline (brominated sponge component) showed only a significant inhibitory activity toward glycogen synthase kinase 3β with IC 50 3 μmol [5] .
Stylissa carteri (syn. Axinella carteri) is one of the interesting sponges from the Red Sea. Several bromopyrrole alkaloids were isolated from it; namely, debromohymenialdisine, hymenialdisine and 3-bromohymenialdisine exhibited cytotoxic activities on L5178Y mouse lymphoma cell lines. They displayed ED 50 values 1.8, 3.9 and 3.9 μg/mL, respectively [6] .
Moreover, 10-E-hymenialdisine and 10-Z-hymenialdisine showed a potent inhibition of RAF/MEK-1/MAPK cascade with IC 50 values of 3 and 6 nM, respectively. Both of these alkaloids also inhibited the growth of human LoVo tumor cells [7] . Furthermore, hymenialdisine competed with ATP for binding to distinct kinases, like cyclin-dependent kinases, glycogen synthase kinase-3β and casein kinase 1 [8] . Also, it inhibited interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB [9] . Finally, a dimeric oroidin derivative carteramine A was isolated as a neutrophil chemotaxis inhibitor from S. carteri [10] .
Therefore, this study aimed the investigation of the biological activities of the isolated alkaloids from S. carteri, namely, in vitro protein kinase activities and cytotoxic effects using different cell lines.
Materials and methods

Animal material
The sponge S. carteri (syn. A. carteri) (Phylum: Porifera, Class: Demospongiae, Order: Halichondrida, Family: Dictyonellidae, Genus: Stylissa, Species: S. carteri) was collected in June 2006 at a depth of 12 m, from the Red Sea, Hurghada, Egypt. It was identified by Prof. van Soest, RWM (Zoological Museum; Amsterdam, The Netherlands). It is a reddish orange flabellate sponge. The sponge material was immersed in ethanol immediately after collection. A voucher specimen was kept in ethanol under registration number (ZMAPOR 19838) . TLC analyses were carried out using aluminum sheet precoated with silica gel 60 F 254 (Merck). The compounds were detected by their UV absorbance at 254 and 366 nm.
Analytical HPLC analysis
The samples were injected into a HPLC system equipped with a photodiode array detector (Dionex, Munich, Germany). The routine detections were at 235, 254, 280 and 340 nm. The separation column (125 × 4 mm ID) was prefilled with Eurosphere 100-5 RP-18, 5 μm (Knauer, Berlin, Germany) and flow rate 1 mL/min. The separation was achieved by applying a linear gradient from 90% H 2 O (pH 2.0 Nanopure water using ortho-phosphoric acid 85% p.a., Merck) to 100% MeOH over 40 min.
Semi-preparative HPLC
The separations were done on a LaChrom-Merck Hitachi HPLC machine, pump L-7100 and UV detector L-7400. The separation column (300 × 8 mm ID) was prefilled with Eurosphere 100-5 RP-18, 5 μm (Knauer, Berlin, Germany), flow rate 5 mL/min, UV detection at 280 nm. The compounds were eluted with a solvent system of MeOH/nanopure H 2 O (gradient elution starting with a concentration of 10% MeOH and increasing the concentration of MeOH in a linear manner within 25 min up to 60%).
Medium pressure liquid chromatography (MPLC)
The separations were done on Büchi MPLC (Switzerland), gradient molder with mixing chamber B-687, fraction collector B-684 and column size (460 × 26 mm ID 
Spectroscopic, mass and optical activity analyses
1D and 2D NMR spectra were recorded at 300 K on either a Bruker ARX-500 or an AVANCE DMX-600 NMR spectrometer. Samples were dissolved in different deuterated solvents, whose choice was dependent on the solubility of each compound. Mass spectra (ESI-MS) were recorded on a Thermo Finnigan LCQ DECA mass spectrometer coupled to an Agilent 1100 HPLC system equipped with a photodiode array detector. Optical rotation was determined on a Perkin-Elmer-241 MC polarimeter.
Extraction and isolation
The dried fine powder of S. carteri (600 g) was extracted exhaustively with methanol (4 ×, 3 L each) and concentrated to yield (90 g) residue. The resulting extract was dissolved in the least amount of demineralized water and partitioned with EtOAc and n-BuOH, respectively.
The extraction and fractionation are demonstrated in Scheme 1a.
The n-BuOH-soluble material of S. carteri was concentrated under vacuum to afford (18 g ). It was subjected to column chromatography on sephadex LH-20 using methanol as a mobile phase. Four fractions were obtained (I-IV). Fraction I (3.05 g) was further subjected to RP-18 using acetonitrile as a mobile phase to yield compound 1 (6 mg as a mobile phase to afford compounds 3 (5 mg) and 4 (2 mg), respectively. In addition, Subfr. II-3 (30 mg) was further purified on semipreparative HPLC to obtain compound 5 (8 mg). On the other hand, fraction III (4.9 g) was further subjected to MPLC using RP-18 and MeOH/H 2 O (2.5:7.5) as an isocratic elution system to yield eight subfractions (Subfr. III-1 to III-8). Subfr. III-3 (80 mg) was further purified using semipreparative HPLC to afford three compounds: 6 (3 mg), 7 (2 mg) and 8 (4 mg), respectively. Also, Subfr. III-6 (30 mg) was submitted to further purification using semi-preparative HPLC to give compound 9 (5 mg). Furthermore, Subfr. III-7 (30 mg) was subjected to semi-preparative HPLC to give compound 10 (7 mg). Finally, compound 11 (10 mg) was precipitated in pure form from subfraction (Subfr. III-8). Chromatographic separations of n-butanol fraction are illustrated in Scheme 1b. Additionally, the EtOAc soluble material of S. carteri was concentrated under vacuum to yield (12 g). It was subjected to VLC on silica gel, using gradient elution consisting of different portions of n-hexane/CH 2 Cl 2 to CH 2 Cl 2 / MeOH. Elution started with 100% n-hexane and CH 2 Cl 2 concentrations were increased gradually till 100% CH 2 Cl 2 and then MeOH concentrations were increased gradually till 100% MeOH. Ten fractions were obtained (I-X). Compound 12 (3 mg) was precipitated as a pure substance from fraction VII, while fraction IX (0.5 g) was further subjected to silica gel column chromatography using CH 2 Cl 2 /MeOH in a gradient elution manner to yield seven subfractions (Subfr. IX-1 to IX-7). Subfr. IX-4 (110 mg) was further purified by RP-18 using acetonitrile as a mobile phase to afford three compounds: 13 (8 mg), 14 (6 mg) and 15 (2 mg). Chromatographic purifications of EtOAc fraction are shown in Scheme 1c.
Protein kinase assay
Assays for the measurement of protein kinase activity were performed in 96-well FlashPlates (Perkin-Elmer/ NEN, Boston, MA, USA) in a 50 mL reaction volume. The reaction cocktail contained 20 μL assay buffer, 5 μL ATP solution (in demineralized water), 5 μL tested compound (in 10% DMSO), 10 μL substrate and 10 μL purified recombinant protein kinase. The final concentration of ATP was 1 mM. The assay for all enzymes contained 60 mM HEPESNaOH, pH 7.5, 3 mM MgCl 2 , 3 mM MnCl 2 , 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/mL PEG 20,000 and 1 μM [γ- P was determined with a microplate scintillation counter (Microbeta Trilux, Wallac). All assays were performed with a Beckman Coulter/Sagian robotic system [11, 12] .
The following substrates were used: AKT1, substrate [GSK3 (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) 
Cytotoxicity test
The cytotoxicity was determined by using two different cell lines.
L5178Y cell lines
They were grown in Eagle's minimal essential medium supplement with 10% horse serum in roller tube culture. The medium contained 100 units/mL penicillin and 100 μg/mL streptomycin. The cells were maintained in a humidified atmosphere at 37 °C with 5% CO 2 . An aliquot of 50 μL cell suspension (3750 cells) was pipetted into each cavity of a 96-well microtiter plate together with 50 μL of the compounds in EMEM (3-10 μg/mL) and incubated for 72 h (37 °C, 5% CO 2 ). A solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma) was prepared at 5 mg/mL in phosphate buffered saline (1.5 mM KH 2 PO 4 , 6.5 mM Na 2 HPO 4 , 137 mM NaCl, 2.7 mM KCl; pH 7.4) and from this solution, 20 μL was pipetted into each well. The yellow MTT penetrates the healthy living cells and in the presence of mitochondrial dehydrogenases, MTT is transformed to its blue formazan complex. After an incubation period of 3 h (37 °C, 5% CO 2 ), the medium was centrifuged (15 
Agelongine (2) [17]
Yellow residue. UV (MeOH) λ max : 217.1, 234.0 and 271.8 nm. 
(−) 3-Bromomanzacidin D (N-methylmanzacidin C) (4) [19]
Yellow residue. UV (MeOH) λ max : 218.1 and 276.3 nm. and the cells were lysed by DMSO to liberate the formed formazan product. After thorough mixing, the absorbance was measured at 520 nm using a scanning microtiter-well spectrophotometer [13, 14] . The negative control media with 0.1% DMSO were included in the experiments. All experiments were carried out in triplicates. The intensity of the color is dependent on the number of healthy living cells; therefore, cell survival percentage was estimated employing the following formula:
(Absorbance of treated cells Absorbance of culture medium) Survival(%) 1 00 (Absorbance of untreated cells Absorbance of culture medium)
HCT116 cell lines
They were evaluated according to Mosmann [14] with slight modifications [15] .
Statistical analyses
All data are given as mean ± SD. The significance of changes in the test responses was assessed using analysis of variance (GraphPad Prism: version 5.0, La Jolla, CA, USA). Statistical significance was assessed by unpaired Student's t-test, differences were considered to be significant at p < 0.05 and indicated as "*". 
Results
Isolation of the pyrrole alkaloids
(−) Clathramide C (1) [16]
Yellow residue. UV (MeOH) λ max : 221. 5 
(+) Dibromophakelline (5) [20]
Brown residue. UV (MeOH) λ max : 237.1 and 289.4 nm. 
E-Debromohymenialdisine (6) [21]
Yellow amorphous powder. UV (MeOH) λ max : 212.0, 240.5 and 362.1 nm. 
(±) Ageliferin (11) [23]
Brown residue. 
Aldisine (13) [25]
Yellow residue. UV (MeOH) λ max : 220.5, 250.4 and 303.9 nm. 
2-Bromoaldisine (14) [25]
Yellow amorphous powder. UV (MeOH) λ max : 233.9 and 311.1 nm. 
Protein kinase inhibition
Protein kinases are sensitive targets for various pharmacological purposes, e.g. VEGF-R2 is an important target in cancer therapy. This kinase was inhibited by distinct brominated pyrrole derivatives from S. carteri, namely, E-debromohymenialdisine (6), Z-spongiacidin D (7), Z-hymenialdisine (8), Z-3-bromohymenialdisine (9) and 3,4-dibromo-1H-pyrrole-2-carbamide (12) . Z-Spongiacidin D (7) was shown to be the most active compound. It also inhibited AKT1, ARK5, AURORA-A, B-RAF-VE, CDK2/ CycA, CDK4/CycD1, FAK, IGF1-R, SRC, COT, PLK-1, SAK and PDGFR-beta. A nearly similar activity profile showed by Z-3-bromohymenialdisine (9), which inhibited AURORA-A, AURORA-B, CDK4/CycD1, FAK, SRC, COT, PLK1, SAK and PDGFR-beta. Also, Z-hymenialdisine (8) was able to inhibit the activity of AKT1, ARK5, CDK2-CycA, CDK4/ CycD1, FAK, COT, PLK1, SAK and PDGFR-beta. However, (−) clathramide C (1), agelongine (2), (+) manzacidin A (3), E-debromohymenialdisine (6) and 3,4-dibromo-1H-pyrrole-2-carbamide (12) showed only a slight protein kinase inhibition. Finally, all other compounds were not active. The protein kinase inhibitory profiles of the active compounds are summarized in Table 1 .
Cytotoxicity activity
All compounds were subjected to determine their cytotoxicity in vitro employing L5178Y and HCT116 cell lines.
In the L5178Y cell line, (+) dibromophakelline (5) and Z-3-bromohymenialdisine (9) showed cytotoxic activities with inhibition of growth 57.0% and 60.5%, respectively (10 μg/mL), while the cytotoxicity of (−) clathramide C (1), Z-spongiacidin D (7), Z-hymenialdisine (8) and 3,4-dibromo-1H-pyrrole-2-carbamide (12) was not as prominent (growth inhibition of 25.3%, 36.7%, 37.0% and 38.4%, respectively). However, agelongine (2), (+) manzacidin A (3), (−) 3-bromomanzacidin D (4), E-debromohymenialdisine (6), 2-debromostevensine (10), (±) ageliferin (11), aldisine (13), 2-bromoaldisine (14) and 4-bromo-1H-pyrrole-2-carbamide (15) showed no significant cytotoxic activity in this cell line. The results are demonstrated in Figure 2 . The cytotoxic activities were further analyzed on the HCT116 cell line. In accordance with the results, which were obtained on L5178Y cell lines, Z-3-bromohymenialdisine (9) and Z-hymenialdisine (8) exerted relatively high toxicity (significant effects at 25 μM after 24 h). A relatively high toxicity was also caused by (±) ageliferin (11) . All other analyzed compounds showed no significant cytotoxic effect up to concentrations of 50 μM. The results are illustrated in Figure 3. 
Discussion
Marine sponges are of great pharmacological interest due to the diversity of their secondary metabolites. Although the molecular mode of action of the most metabolites is still unclear, for a substantial number of compounds, the mechanisms by which they interfered with the pathogenesis of a wide range of diseases have been reported. Marine distinct secondary metabolites possessed antiviral, antitumor, anti-inflammatory, anti-oxidative, antibiotic or immunosuppressive activity. Due to these important biological activities, sponges have the potential to provide future drugs against diseases like cancer, malaria and inflammatory diseases [2, 29] .
The current study was performed for the first time on the inhibitory effects of the compounds using 21 important protein kinases in vitro. Despite the molecular similarity of distinct compounds (only marginal changes in structures), the effects of the compounds on protein kinase inhibition remained to be strongly dependent on the distinct structures. Z-Spongiacidin D (7) exhibited the highest capacity to inhibit protein kinases. A potent inhibition of ARK5, CDK2/CycA, CDK4/CycD1, VEGF-R2, SAK and PDGFR-beta was detected by this compound. The structurally related dibrominated compound Z-3-bromohymenialdisine (9) was also very potent, but with a slight different inhibition pattern of Z-spongiacidin D (7). In the dibrominated compound Z-3-bromohymenialdisine (9) , no inhibition of AKT1, ARK5, B-RAF-VE, CDK2/CycA and IGF1-R was detected, but in case of AURORA-A and FAK, a higher inhibitory effect was seen. E-Debromohymenialdisine (6) and Z-hymenialdisine (8) were structurally similar to the previously mentioned compounds, but less potent. Since, E-debromohymenialdisine (6) is a non-brominated compound, but also possessed protein kinase inhibitory activity, it has to be concluded that this structural element is no necessity.
Protein kinase inhibition by hymenialdisine was already reported [4] , especially kinases of the cell cycle seems to be affected. Also, it interacted with CDC2-like kinase 1 [30] and showed CHK1-modulatory effects of hymenialdisine analogs [31] . Moreover, it displayed an inhibition of checkpoint kinase by a hymenialdisinederived analog [32] . This was congruent with our finding of the inhibition of CDK2/CycA and CDK4/CycD1. The effect of hymenialdisine/hymenialdisine analogs on 60 recombinant kinases was investigated systematically. They reported 11 new targets, namely, p90RSK, KDR, c-Kit, Fes, MAPK1, PAK2, PDK1, PKCθ, PKD2, Rsk1 and SGK. They also reported that these analogs enhanced and/ or dramatically altered selectivity relative to hymenialdisine [33] . This result was also matching to our findings; Z-spongiacidin D (7) and Z-3-bromohymenialdisine (9) showed a higher activity compared with Z-hymenialdisine (8) . This study reported an inhibition of ARK5 by Z-hymenialdisine, as well as VEGF-R2 and a weaker effect of this compound to inhibit AKT1, CDK2/CycA, CDK4/CycD1, FAK, COT, PLK1, SAK and PDGFR-beta. To the best of our knowledge, no report about, e.g. inhibition of AURORA-A and AURORA-B by hymenialdisine/hymenialdisine analogs existed in the literature.
This study was further performed to check the cytotoxicity of isolated compounds on the tumor cells. In L5178Y cell line, the potent compounds [(+) dibromophakelline (5) and Z-3-bromohymenialdisine (9)] showed a significant inhibition of cell growth. Moreover, Z-spongiacidin D (7), Z-hymenialdisine (8) and 3,4-dibromo-1H-pyrrole-2-carbamide (12) showed a moderate inhibition of cell growth, while the other compounds were not or only marginal toxic. The dibrominated compounds, namely, (+) dibromophakelline (5) and Z-3-bromohymenialdisine (9), showed a comparable high toxicity, while the dibrominated compound like (±) ageliferin (11) showed very weak toxicity. This indicates no structural activity relationship between brome atoms in these alkaloids and cytotoxicity.
On the other hand, Z-hymenialdisine (8), Z-3-bromohymenialdisine (9) and (±) ageliferin (11) showed a relatively high cytotoxic effect on the HCT116 cell line. Consequently, this study demonstrated that the monobrominated compound Z-hymenialdisine (8) and the dibrominated compound [Z-3-bromohymenialdisine (9)] had cytotoxic effects against the two cell lines. To the best of our knowledge, no reported toxicity of ageliferin existed in the literature.
Conclusions
Fifteen compounds, mostly monobrominated pyrrole alkaloids, isolated from S. carteri had protein kinase inhibitory activity and cytotoxicity. The most potent compounds were Z-spongiacidin D (7), Z-hymenialdisine (8) and Z-3-bromohymenialdisine (9) . From the results of protein kinase, inhibition and cytotoxicity displayed a good correlation, as distinct brominated pyrrole alkaloids effectively inhibited distinct protein kinases followed by a toxic mode of action. These compounds may be interesting for prospective uses as pharmacological drugs. In conclusion, distinct pyrrole alkaloids isolated from S. carteri effectively inhibited distinct protein kinases in vitro suggesting potential uses as pharmacological medications.
Supplementary material
NMR and UV spectra of the isolated compounds 1-15 (Supplementary material, Figures S1-S15 ).
